Capital 10X had the pleasure of sitting down with Kim Rivers, CEO of Trulieve (CSX:TRUL, OTC:TCNNF) to discuss their latest medical cannabis geographic expansion into Pennsylvania through the acquisitions of PurePenn and Solevo.
Kim also discusses opportunities for further growth and differentiates between recreational and medical markets. She also helps us understand the drivers that have enabled Trulieve to have best-in-class returns on equity in the Cannabis Industry.
The opinions provided in this article are those of the author and do not constitute investment advice. Readers should assume that the author and/or employees of Capital 10X hold positions in the company or companies mentioned in the article. For more information, please see our Content Disclaimer.